Global Wearable Injectors Market

Global Wearable Injectors Market Size, Share, Growth Analysis, By Type(On-Body, Off-Body), By Therapy(Diabetes, Cardiovascular disease) - Industry Forecast 2023-2030


Report ID: SQSG35B2020 | Region: Global | Published Date: February, 2024
Pages: 263 | Tables: 63 | Figures: 76

Global Wearable Injectors Market Insights

Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).

Wearable injectors are delivery methods that stick to the skin and allow for long-term subcutaneous drug administration. The equipment in wearable injectors gives more accurate dosing, along with other clinical advantages, and higher delivery precision. The components of any wearable injector are the same: a reservoir for medication, a cannula for tissue supply, an adhesion to secure the equipment to the skin's surface, and a driving mechanism to provide the right amount of medication.

Comparing wearable injectors to traditional injecting techniques, they are a more affordable form of administration. The market for wearable injectors is expected to develop as a result of the advantages these devices have over traditional injections, including better drug dose and time control, enhanced patient ease and satisfaction, and a decrease in methodological problems. But throughout the projected timeline, unfavorable reimbursement rules are expected to slow the rising demand for wearable injectors.

US Wearable Injectors Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 6.66 billion

Fastest Growth

Off-body

Growth Rate

15.29% CAGR

Global Wearable Injector Market, 2021-2028($ Bn)
Country Share for North America Region- 2021 (%)
Global Wearable Injector Market Size By Type 2021-2028(%)

To get more reports on the above market click here to Buy The Report

Global Wearable Injectors Market Segmental Analysis

The global wearable injectors market segmentation is based on type, therapy, and region. Based on type the market is segmented into on-body and off-body. Based on therapy the market is segmented into diabetes, cardiovascular disease, immuno-oncology, and others. Based on region the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Wearable Injectors Market Analysis by Type

In 2021, the on-body market category held the highest market share. Particularly on the stomach, these feel comfortable against the body. In-home care settings can also utilize them easily because they are waterproof. Additionally, it is predicted that the segment would develop faster in the years to come due to an increase in the market for home care. However, the prediction predicts that off-body injectors will increase the most in the coming few years. Off-body injectors have gained popularity as a result of the drawbacks of on-body injectors, such as unpleasant withdrawal, contact dermatitis and irritation, and problems with adhesive compatibility.

Wearable Injectors Market Analysis by Therapy

The wearable injectors market saw a major revenue share in the Cardiovascular diseases category in 2021. The global increase in the prevalence of sedentary lifestyles is blamed for the sector's continuous rise. Heart and blood vascular issues are grouped together as CVDs. A blockage that prevents blood from getting to the heart or brain usually results in abrupt events like heart attacks and strokes. The most frequent cause is an accumulation of fatty deposits on the inside lining of the blood vessels that supply the heart/brain. 

Global Wearable Injector Market By Type, 2021(%), 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global Wearable Injectors Market Regional Insights

In terms of revenue, North America held the largest wearable injector market globally in 2021, and it is expected that it will continue to do so during the projection timeframe. This is explained by the spike in the number of people with various medical conditions. Furthermore, the requirement for the wearable injector market is being fueled by the introduction of numerous novel medications that may successfully cure chronic diseases. Additionally, the growing acceptance of tailored pharmaceuticals may have a favorable effect on the market in the years to come.

The most potential market is expected to be in the Asia Pacific over the forecast years. Several of the world's top biotech producers are based in the Asia Pacific. The industry competitors can expect profitable prospects in the near future from countries like South Korea, China, and India. Additionally, it is predicted that the region's aging population will increase the market for wearable injectors. The aging population is more susceptible to many chronic diseases and is projected to drive market expansion in the coming years.

Global Wearable Injector Market By Geography, 2021-2028, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Wearable Injectors Market Dynamics

Wearable Injectors Market Driver

  • The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.
  • Since biologics and mAbs must be administered parenterally, greater emphasis on their use to cure conditions like cancer, rheumatoid arthritis, and heart disease would open up significant development opportunities for wearable injectors that deliver drugs subcutaneously, intravenously, or intramuscularly. In past years, a sizable number of biologics were also being developed, and the amount of biologic pharmaceuticals under development is still growing rapidly. 

Wearable Injectors Market Restraint

  • Due to the costs and hassles associated with conservative settings, people have been compelled to switch to more affordable choices, leading to favor for such injectors. These injectors offer benefits like ease of administration, pain relief, and decreased untimeliness when connected to syringes, all of which contribute to market growth.
  • Wearable injectors are not widely available in many countries due to unfavorable reimbursement policies. Several developing countries do not pay for wearable injectors. Wearable injector accessibility and adoption are directly impacted by the lack of reimbursement.

Request Free Customization of this report to help us to meet your business objectives.

Global Wearable Injectors Market Competitive Landscape

Many businesses in the market for producing wearable injectors are now concentrating on expanding their production capacities through mergers and acquisitions. For the purpose of acquiring new features or gaining entry into new markets, large primary manufacturers are creating joint ventures or purchasing small or midsized businesses. Additionally, businesses are investing in the creation of enhanced products. They are also concentrating on keeping their prices competitive. For instance, in April 2021, the Medtronic Extended infusion set is the first and only infusion set that may be worn for up to 7 days, according to an announcement made by Medtronic plc.

Top Players in the Global Wearable Injector Market

  • Ypsomed
  • Amgen
  • Subcuject (Denmark)
  • Becton, Dickinson and Company (BD)
  • Bespak Europe Ltd.
  • CeQur SA
  • Debiotech SA
  • Enable Injections
  • Insulet Corporation
  • Medtronic plc
  • Mylan N.V.
  • Nemera Development S.A.
  • Omron Corporation
  • Pfizer Inc.
  • Roche Holding AG
  • Sensile Medical AG
  • SteadyMed Therapeutics, Inc.
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • West Pharmaceutical Services, Inc.
  • Zosano Pharma Corporation

Wearable Injectors Market Recent Development

  • In January 2022, Insulet's Omnipod 5, an automated insulin delivery system, was given the US FDA's nod. With this certification, the business hoped to launch the first wearable tubeless automated insulin administration device by fusing the Omnipod 5 with Dexcom's G6 continuous glucose monitoring system. Additionally, individuals using this device would be able to use a specialized portable remote or mobile to operate the system.
  • In April 2021, Five Prime Therapeutics, a clinical-stage biotechnology company that specializes in creating immuno-oncology and targeted cancer medications, has been officially acquired by Amgen. Amgen thinks that by acquiring Five Prime, it will be able to use bemarituzumab, a first-in-class treatment for gastric cancer, to help patients with stomach cancer.

Global Wearable Injectors Key Market Trends

  • The rising popularity of at-home, self-administered injectors for treating illnesses with little chance of dosage error and needle stick injuries. Other growth-promoting aspects include a number of product developments, such as the incorporation of Bluetooth, wireless communication, and passive warning systems with injectors. These innovations allow for comfortable patient monitoring via a mobile application and offer prompt medication reminders.

Global Wearable Injectors Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the on-body market sector had the most market share in 2021. In 2021, the market for wearable injectors witnessed a significant revenue share in the cardiovascular diseases sector. In terms of revenue, North America led the global wearable injector market in 2021, and it's expected that this trend will hold during the forecast period. Over the projected years, Asia Pacific is expected to have the highest market potential.

Report Metric Details
Market size value in 2021 USD 6.66 billion
Market size value in 2030 USD 23.89 billion
Growth Rate 15.29%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • On-Body, Off-Body
  • Therapy
    • Diabetes, Cardiovascular disease, Immuno-oncology, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Ypsomed
  • Amgen
  • Subcuject (Denmark)
  • Becton, Dickinson and Company (BD)
  • Bespak Europe Ltd.
  • CeQur SA
  • Debiotech SA
  • Enable Injections
  • Insulet Corporation
  • Medtronic plc
  • Mylan N.V.
  • Nemera Development S.A.
  • Omron Corporation
  • Pfizer Inc.
  • Roche Holding AG
  • Sensile Medical AG
  • SteadyMed Therapeutics, Inc.
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • West Pharmaceutical Services, Inc.
  • Zosano Pharma Corporation
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Wearable Injectors Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Wearable Injectors Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Wearable Injectors Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Wearable Injectors Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Wearable Injectors Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Wearable Injectors Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).

Many businesses in the market for producing wearable injectors are now concentrating on expanding their production capacities through mergers and acquisitions. For the purpose of acquiring new features or gaining entry into new markets, large primary manufacturers are creating joint ventures or purchasing small or midsized businesses. Additionally, businesses are investing in the creation of enhanced products. They are also concentrating on keeping their prices competitive. For instance, in April 2021, the Medtronic Extended infusion set is the first and only infusion set that may be worn for up to 7 days, according to an announcement made by Medtronic plc. 'Ypsomed', 'Amgen', 'Subcuject (Denmark)', 'Becton, Dickinson and Company (BD)', 'Bespak Europe Ltd.', 'CeQur SA', 'Debiotech SA', 'Enable Injections', 'Insulet Corporation', 'Medtronic plc', 'Mylan N.V.', 'Nemera Development S.A.', 'Omron Corporation', 'Pfizer Inc.', 'Roche Holding AG', 'Sensile Medical AG', 'SteadyMed Therapeutics, Inc.', 'Tandem Diabetes Care, Inc.', 'United Therapeutics Corporation', 'West Pharmaceutical Services, Inc.', 'Zosano Pharma Corporation'

The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.

The rising popularity of at-home, self-administered injectors for treating illnesses with little chance of dosage error and needle stick injuries. Other growth-promoting aspects include a number of product developments, such as the incorporation of Bluetooth, wireless communication, and passive warning systems with injectors. These innovations allow for comfortable patient monitoring via a mobile application and offer prompt medication reminders.

In terms of revenue, North America held the largest wearable injector market globally in 2021, and it is expected that it will continue to do so during the projection timeframe. This is explained by the spike in the number of people with various medical conditions. Furthermore, the requirement for the wearable injector market is being fueled by the introduction of numerous novel medications that may successfully cure chronic diseases. Additionally, the growing acceptance of tailored pharmaceuticals may have a favorable effect on the market in the years to come.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Wearable Injectors Market

Product ID: SQSG35B2020

$5,300
BUY NOW GET FREE SAMPLE